Cellumen to Collaborate with Mayo Foundation on Breast Cancer Patient Stratification | GenomeWeb
NEW YORK (GenomeWeb News) - Cellumen said today that it will collaborate with the Mayo Foundation for Medical Education and Research to apply the company’s cellular systems biology approach to breast cancer patient stratification.
 
Cellumen said that the goal of the project is to create a breast cancer patient profile test to help improve disease treatment and diagnosis.
 
"We are treating breast tumors as a 'system' within the breast cancer patient," said Cellumen's CEO, Lansing Taylor.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.